From April 12, 2024 to May 13, 2024, the company has repurchased 350,000 shares, representing 2.23% for ¥868.86 million. With this, the company has completed the repurchase of 350,000 shares, representing 2.23% for ¥868.86 million under the buyback announced on April 12, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,206 JPY | -1.87% | -3.46% | +15.80% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.80% | 219M | |
+17.22% | 42.25B | |
+15.37% | 21.27B | |
+19.33% | 15.23B | |
+19.22% | 14.36B | |
+50.44% | 12.74B | |
-0.05% | 6.79B | |
-12.40% | 6.61B | |
-8.87% | 5.73B | |
+14.28% | 5.66B |
- Stock Market
- Equities
- 4577 Stock
- News Daito Pharmaceutical Co.,Ltd.
- Tranche Update on Daito Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on April 12, 2024.